Advisors
ASSESS is supported by some of the top global thought leaders and methodologists.
Sir Andrew Dillon
Advisor
Andrew Dillon graduated from the University of Manchester in 1975. He held several senior management positions in the UK National Health Service, including General Manager of the Royal Free Hospital and Chief Executive of St George's Hospital, both academic health centres in London. He was the founding Chief Executive of NICE, the National Institute for Health and Care Excellence in England from 1999 to 2020. He is now a visiting professor at the Institute of Global Health Innovation, Imperial College, London and works as an independent consultant.
Dr. Daniel Ollendorf
Advisor
Daniel A. Ollendorf, PhD, is the Chief Scientific Officer at the Institute for Clinical and Economic Review (ICER), and is Director of Value Measurement and Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center. Dr. Ollendorf currently serves as a non-resident Fellow at the Center for Global Development, and as Chair of the Health Technology Assessment International (HTAi) Global Policy Forum.
Dr. Richard Edlin
Advisor
Dr. Richard Edlin is a Senior Lecturer in Health Economics at the School of Population Health at the University of Auckland. His research centres around the use and interpretation of preferences in informing health care decision making, although he contributes towards economic evaluations alongside clinical trials and decision analytic modelling. He is the first author of a textbook on Health Technology Assessment held in 250 libraries worldwide and has a keen interest in the effective communication and dissemination of health economic methodology. Most of his current applied research is in the area of Women and Children's Health.
Dr. Paula Lorgelly
Advisor
Dr. Paula Lorgelly is Chair, Health Economics at The University of Auckland. Previously, she was Professor of Health Economics in the Department of Applied Health Research at University College London. Paula has over 20 years' experience working in academia in the United Kingdom, Australia and New Zealand and the independent sector in the United Kingdom. Whilst in Australia she was a member of the Economics Sub-Committee of the Pharmaceutical Benefits Advisory Committee (PBAC). Paula has worked across the health and medical spectrum and much of her clinical research has focused on oncology, particularly genomics and precision medicine. More recently she has begun working in the digital health/digital technology space.